1.
Silverberg J, Pink A, Olsen C, Weidinger S. Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.24];4(6):s99. Available from: https://jofskin.org/index.php/skin/article/view/1076